57 related articles for article (PubMed ID: 38544483)
1. Mature T-cell and NK-cell lymphomas: updates on molecular genetic features.
Lewis NE; Sardana R; Dogan A
Int J Hematol; 2023 Apr; 117(4):475-491. PubMed ID: 36637656
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of mature T- and NK-cell lymphomas.
Jia J; Wang X; Song Z; Meng S; Fei Y; Yu J; Liu X; Han X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Wang X; Zhang H
Cancer Biol Med; 2024 Mar; 21(3):223-9. PubMed ID: 38544483
[No Abstract] [Full Text] [Related]
3. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas.
Lien HC; Lin CW; Huang PH; Chang ML; Hsu SM
Lab Invest; 2000 Jun; 80(6):893-900. PubMed ID: 10879740
[TBL] [Abstract][Full Text] [Related]
5. Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas.
Lin CW; Lee WH; Chang CL; Yang JY; Hsu SM
Am J Pathol; 2001 Nov; 159(5):1671-9. PubMed ID: 11696428
[TBL] [Abstract][Full Text] [Related]
6. Treatment algorithms for mature T-cell and natural killer-cell neoplasms.
Tse E; Kwong YL
Future Oncol; 2011 Sep; 7(9):1101-12. PubMed ID: 21919697
[TBL] [Abstract][Full Text] [Related]
7. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
[TBL] [Abstract][Full Text] [Related]
8. Current cancer burden in China: epidemiology, etiology, and prevention.
Maomao C; He L; Dianqin S; Siyi H; Xinxin Y; Fan Y; Shaoli Z; Changfa X; Lin L; Ji P; Wanqing C
Cancer Biol Med; 2022 Aug; 19(8):1121-38. PubMed ID: 36069534
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia.
Yoon SE; Song Y; Kim SJ; Yoon DH; Chen TY; Koh Y; Kang KW; Lee HS; Tay KKW; Lim ST; Poon M; Irawan C; Zhao W; Do YR; Lee MH; Ng SC; Lee WS; Guo Y; Zhang H; Kang HJ; Yun HJ; Kim HJ; Lung DTC; Kwak JY; Han JJ; Mun YC; Oh SY; Shim H; Kwon JH; Sohn BS; Park SK; Jo JC; Ko YH; Jun Z; Kim WS
Lancet Reg Health West Pac; 2021 May; 10():100126. PubMed ID: 34327343
[TBL] [Abstract][Full Text] [Related]
10. The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study.
Zhang W; Su L; Liu L; Gao Y; Wang Q; Su H; Song Y; Zhang H; Shen J; Jing H; Wang S; Cen X; Liu H; Liu A; Li Z; Luo J; He J; Wang J; O'Connor OA; Zhou D
Cancer Biol Med; 2021 Mar; 18(3):841-8. PubMed ID: 33755379
[TBL] [Abstract][Full Text] [Related]
11. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
Chen SY; Yang Y; Qi SN; Wang Y; Hu C; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Wu T; Zhu SY; Shi M; Xu LM; Yuan ZY; Yahalom J; Tsang R; Song YQ; Zhu J; Su H; Li YX
Leukemia; 2021 Jan; 35(1):130-142. PubMed ID: 32152465
[TBL] [Abstract][Full Text] [Related]
12. Genetic Landscape and Classification of Peripheral T Cell Lymphomas.
Sandell RF; Boddicker RL; Feldman AL
Curr Oncol Rep; 2017 Apr; 19(4):28. PubMed ID: 28303495
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy.
Li YY; Feng LL; Niu SQ; Wang HY; Zhang LL; Wang L; Xia ZJ; Huang HQ; Xia YF; Zhang YJ; Wang XC
Oncotarget; 2017 Feb; 8(7):11480-11488. PubMed ID: 28002792
[TBL] [Abstract][Full Text] [Related]
14. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
